Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Kent

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Virology|August 16, 2001
Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivoS J Kent, P U Cameron, J C Reece, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failureS J Kent, P D Greenberg, M C Hoffman, et al.
Vaccine|March 16, 2000
A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaquesS J Kent, A Zhao, C J Dale, et al.
Immunological Reviews|December 3, 1999
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunityA J Ramsay, S J Kent, R A Strugnell, et al.
Journal of Medical Primatology|November 21, 2000
Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gammaC J Dale, A Zhao, S L Jones, et al.
The Journal of Clinical Investigation|January 1, 1995
Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrinaS J Kent, L Corey, M B Agy, et al.
AIDS (London, England)|October 1, 1992
Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicityM A Slavin, J F Hoy, K Stewart, et al.
Journal of Virology|November 13, 1998
Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virusS J Kent, A Zhao, S J Best, et al.
Clinical and Experimental Immunology|February 4, 2015
Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activationC-C Tang, G Isitman, J Bruneau, et al.
Australian Veterinary Journal|August 9, 2001
Simian immunodeficiency virus infections in vervet monkeys (Clorocebus aethiops) at an Australian zooA Joy, L Vogelnest, D J Middleton, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Virology|August 16, 2001
Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivoS J Kent, P U Cameron, J C Reece, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failureS J Kent, P D Greenberg, M C Hoffman, et al.
Vaccine|March 16, 2000
A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaquesS J Kent, A Zhao, C J Dale, et al.
Immunological Reviews|December 3, 1999
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunityA J Ramsay, S J Kent, R A Strugnell, et al.
Journal of Medical Primatology|November 21, 2000
Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gammaC J Dale, A Zhao, S L Jones, et al.
The Journal of Clinical Investigation|January 1, 1995
Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrinaS J Kent, L Corey, M B Agy, et al.
AIDS (London, England)|October 1, 1992
Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicityM A Slavin, J F Hoy, K Stewart, et al.
Journal of Virology|November 13, 1998
Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virusS J Kent, A Zhao, S J Best, et al.
Clinical and Experimental Immunology|February 4, 2015
Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activationC-C Tang, G Isitman, J Bruneau, et al.
Australian Veterinary Journal|August 9, 2001
Simian immunodeficiency virus infections in vervet monkeys (Clorocebus aethiops) at an Australian zooA Joy, L Vogelnest, D J Middleton, et al.
Pageof 6